Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1991 1
1992 1
1995 1
1997 1
2000 1
2001 3
2002 1
2004 2
2005 1
2006 1
2007 3
2008 1
2009 1
2010 3
2012 4
2013 6
2014 2
2015 8
2016 7
2017 8
2018 10
2019 18
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

PubMed for Bookshelf ID: 5045660

81 results

Results by year

Filters applied: . Clear all
Page 1
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients.
Smith TR, Winner P, Aurora SK, Jeleva M, Hocevar-Trnka J, Shrewsbury SB. Smith TR, et al. Headache. 2021 Sep;61(8):1214-1226. doi: 10.1111/head.14184. Epub 2021 Aug 7. Headache. 2021. PMID: 34363701 Free PMC article. Clinical Trial.
Imaging the Premonitory Phase of Migraine.
Karsan N, Goadsby PJ. Karsan N, et al. Front Neurol. 2020 Mar 25;11:140. doi: 10.3389/fneur.2020.00140. eCollection 2020. Front Neurol. 2020. PMID: 32269547 Free PMC article. Review.
Ubrogepant for the Treatment of Migraine.
Dodick DW, Lipton RB, Ailani J, Lu K, Finnegan M, Trugman JM, Szegedi A. Dodick DW, et al. N Engl J Med. 2019 Dec 5;381(23):2230-2241. doi: 10.1056/NEJMoa1813049. N Engl J Med. 2019. PMID: 31800988 Clinical Trial.
81 results